PDIA3 and neoplasm: Use of more sophisticated systems, such as tumor spheroids in vitro or mouse genetic models of cancer, would give a clearer view on, for example, the relative effects of PDIA3 inhibition on primary or metastatic tumors or effects on the ECM and TME over time.